Next Article in Journal
Clinical and Radiological Evaluation of Oral and Maxillofacial Status in Patients Undergoing Antiresorptive Therapy and Its Relationship with MRONJ
Previous Article in Journal
Artificial Intelligence Applications in Chronic Obstructive Pulmonary Disease: A Global Scoping Review of Diagnostic, Symptom-Based, and Outcome Prediction Approaches
Previous Article in Special Issue
Rhapontigenin Suppresses Leptin-Induced Vasculogenic Mimicry by Inhibiting STAT3-Aquaporin-1 Axis in TNBC Cells
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biomedicines
Volume 13
Issue 12
10.3390/biomedicines13123055
biomedicines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Advances in Cancer Biology and Experimental Anticancer Therapies (2nd Edition)

by
Letizia Polito
1,* and
Ewa Gajda
2
1
Department of Medical and Surgical Sciences-DIMEC, General Pathology Section, Alma Mater Studiorum, University of Bologna, 40126 Bologna, Italy
2
Department of Cell Biology and Immunology, Centre of Postgraduate Medical Education, 01-813 Warsaw, Poland
*
Author to whom correspondence should be addressed.
Biomedicines 2025, 13(12), 3055; https://doi.org/10.3390/biomedicines13123055
Submission received: 30 October 2025 / Accepted: 2 December 2025 / Published: 11 December 2025
(This article belongs to the Special Issue Advances in Cancer Biology and Experimental Anticancer Therapies (2nd Edition))
Versions Notes

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Following the invitation from Biomedicines, we launched a second edition of the Special Issue “Advances in Cancer Biology and Experimental Anticancer Therapies”, as we believe it is truly important to continue focusing on advances in cancer biology and experimental antitumor therapies [...]

Share and Cite

MDPI and ACS Style

Polito, L.; Gajda, E. Advances in Cancer Biology and Experimental Anticancer Therapies (2nd Edition). Biomedicines 2025, 13, 3055. https://doi.org/10.3390/biomedicines13123055

AMA Style

Polito L, Gajda E. Advances in Cancer Biology and Experimental Anticancer Therapies (2nd Edition). Biomedicines. 2025; 13(12):3055. https://doi.org/10.3390/biomedicines13123055

Chicago/Turabian Style

Polito, Letizia, and Ewa Gajda. 2025. "Advances in Cancer Biology and Experimental Anticancer Therapies (2nd Edition)" Biomedicines 13, no. 12: 3055. https://doi.org/10.3390/biomedicines13123055

APA Style

Polito, L., & Gajda, E. (2025). Advances in Cancer Biology and Experimental Anticancer Therapies (2nd Edition). Biomedicines, 13(12), 3055. https://doi.org/10.3390/biomedicines13123055

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop